NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/03/2023
Back to search
Official data from USPTO
PHARMADEN PERIOTHERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PHARMADEN PERIOTHERAPY
ST13
US500000076262517Class
5
Filing
76262517
Registration
2665641
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
01/03/2023
Trademark type
Word
Nice classes
5
Filing date
05/29/2001
Registration date
12/24/2002
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/03/2023
Last transaction
01/03/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
06/01/1998
First use in commerce
10/01/1998
Drawing code
1
Owner type
99
Owner location
Fort Myers, FL, US
Examiner
PIGNATELLO, ELIZABETH
Law office
L50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
CUTE AS A BUTTON, LLC
Pharmaden LLC
Representatives
Arne M. Olson OLSON & CEPURITIS, LTD.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
dietary supplement used in the treatment of periodontal disease in humans
Publications
History of USPTO decisions and trademark events.
23 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
01/03/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/03/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/03/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
06/15/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/24/2021
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/16/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/16/2012
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/16/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/16/2012
E89R
TEAS SECTION 8 & 9 RECEIVED
06/07/2012
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
06/27/2008
PLGL
ASSIGNED TO PARALEGAL
06/27/2008
ES8R
TEAS SECTION 8 RECEIVED
06/12/2008
CFIT
CASE FILE IN TICRS
04/03/2008
R.PR
REGISTERED-PRINCIPAL REGISTER
12/24/2002
PUBO
PUBLISHED FOR OPPOSITION
10/01/2002
NPUB
NOTICE OF PUBLICATION
09/11/2002
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/24/2002
CNEA
EXAMINERS AMENDMENT MAILED
03/15/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/05/2001
CNRT
NON-FINAL ACTION MAILED
08/15/2001
DOCK
ASSIGNED TO EXAMINER
08/07/2001
Continuous trademark protection
Get notified about every new filing that threatens PHARMADEN PERIOTHERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.